Literature DB >> 8199175

Sex differences in susceptibility to etiologic factors for peripheral atherosclerosis. Importance of plasma fibrinogen and blood viscosity.

F G Fowkes1, J P Pell, P T Donnan, E Housley, G D Lowe, R A Riemersma, R J Prescott.   

Abstract

Cardiovascular risk factors in men, such as cigarette smoking, hypercholesterolemia, and hypertension, also increase risk in women, but the relative susceptibility to risk factors between the sexes is not established. Our aim was to investigate a wide range of possible etiologic factors in a single population study and identify those that were more strongly related to peripheral atherosclerosis in men or women. We studied personal factors (age and social class), lifestyle factors (smoking, exercise, alcohol intake, and dietary nutrients), and intermediary factors (obesity, diabetes, serum lipids, coagulation, and rheological factors). In the Edinburgh Artery Study in 1988 we measured cardiovascular risk factors in a random population sample of 1592 men and women aged 55 to 74 years. The ankle-brachial pressure index (ABPI), which is inversely related to the degree of peripheral atherosclerosis, was assessed in each subject. Lifetime cigarette smoking was correlated with a lower ABPI equally in men and women (r = -.27, P < .001). Dietary nutrients and alcohol intake were not related differently between the sexes with ABPI. However, recall of strenuous and moderate leisure time exercise during the age range of 35 to 45 years was related more strongly to a higher ABPI in men than in women (P < .05). Plasma fibrinogen, plasma viscosity, and blood viscosity were the only intermediary factors that had stronger univariate correlations with lower ABPI in men than in women. On multivariate analysis, the sex differences persisted for plasma fibrinogen (P < .05) and blood viscosity (P < .001); high-density lipoprotein cholesterol was related to ABPI in men only (sex difference, P < .1).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8199175     DOI: 10.1161/01.atv.14.6.862

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  7 in total

Review 1.  Gender differences and disparities in all-cause and coronary heart disease mortality: epidemiological aspects.

Authors:  Elizabeth Barrett-Connor
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-07-08       Impact factor: 4.690

2.  Differential effect of female gender on coronary artery disease and peripheral artery disease.

Authors:  H W O Roeters van Lennep; H T Westerveld; A H Zwinderman; J E Roeters van Lennep; H Bruins Slot; D W Erkelens; E E van der Wall
Journal:  Neth Heart J       Date:  2002-12       Impact factor: 2.380

3.  Hemostatic Factors and Ischemic Heart Disease Risk Among Postmenopausal Women.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

4.  The reliability of the ankle-brachial index in the Atherosclerosis Risk in Communities (ARIC) study and the NHLBI Family Heart Study (FHS).

Authors:  Beth D Weatherley; Lloyd E Chambless; Gerardo Heiss; Diane J Catellier; Curtis R Ellison
Journal:  BMC Cardiovasc Disord       Date:  2006-02-21       Impact factor: 2.298

5.  Hybrid System for Ex Vivo Hemorheological and Hemodynamic Analysis: A Feasibility Study.

Authors:  Eunseop Yeom; Yang Jun Kang; Sang Joon Lee
Journal:  Sci Rep       Date:  2015-06-19       Impact factor: 4.379

6.  Preparation of Chitosan and Water-Soluble Chitosan Microspheres via Spray-Drying Method to Lower Blood Lipids in Rats Fed with High-Fat Diets.

Authors:  Yi Tao; Hong-Liang Zhang; Yin-Ming Hu; Shuo Wan; Zheng-Quan Su
Journal:  Int J Mol Sci       Date:  2013-02-19       Impact factor: 5.923

7.  Ankle-Brachial Index and Subsequent Risk of Severe Ischemic Leg Outcomes: The ARIC Study.

Authors:  Amy Paskiewicz; Frances M Wang; Chao Yang; Shoshana H Ballew; Corey A Kalbaugh; Elizabeth Selvin; Maya Salameh; Gerardo Heiss; Josef Coresh; Kunihiro Matsushita
Journal:  J Am Heart Assoc       Date:  2021-11-02       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.